![Ole Thastrup](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ole Thastrup
Fondateur chez
2CUREX AB
Profil
Ole Thastrup is the founder of 2cureX ApS, founded in 2006, where the title held is Director & Chief Scientific Officer.
Dr. Thastrup is the founder of 2cureX AB, founded in 2006, where the title held is Chief Executive Officer & Director.
Dr. Thastrup is also the founder of Noapab Holdings A..
Dr. Thastrup is Chief Executive Officer & Director at Ot311 ApS.
Dr. Thastrup is a Member at Novo Nordisk Fonden.
Dr. Thastrup is Head-Drug Design Department & Professor at the University of Copenhagen.
Former positions include Principal at ZymoGenetics, Inc., Principal at Novo Nordisk A, and Head-Biosector at Carlsberg A from 2002 to 2006.
Postes actifs de Ole Thastrup
| Sociétés | Poste | Début |
|---|---|---|
| 2CUREX AB | Fondateur | 01/01/2006 |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Fondateur | 01/01/2006 |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ot311 ApS | Directeur Général | - |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation | Corporate Officer/Principal | - |
Anciens postes connus de Ole Thastrup
| Sociétés | Poste | Fin |
|---|---|---|
| CARLSBERG A/S | Corporate Officer/Principal | 01/01/2006 |
Noapab Holdings A/S
 Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Directeur Technique/Scientifique/R&D | - |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Carlsberg A/S
 Carlsberg A/S Beverages: AlcoholicConsumer Non-Durables Produces and markets beers and soft drinks | Consumer Non-Durables |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation | Miscellaneous |
Noapab Holdings A/S
Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Commercial Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
2cureX AB
 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
Ot311 ApS |
